Customized research for BIOC vs. ABUS!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for BIOC vs. ABUS.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Biocept, Inc. vs. Arbutus Biopharma Corporation

Industry Match! Industry of Both BIOC and ABUS:

Health Care/Life Sciences

BIOC
Data Last Updated: 4 hours ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 65.288M


P/E: N/A

P/S: 11.81

Q P/B: 2.87

Y Rev: 5.53M

Q Rev: 1.45M

Beta: 0.63

BIOC Share Stats

Outstanding Shares

131.10M

Float Shares

131.06M

Percent of Float Short

1.50%

BIOC Insider Stats

Percent Outstanding Insider Ownership

0.42%

Percent Outstanding Institution Ownership

2.7%

BIOC Social Stats

Followers

3

B/S Rating Today

0

B/S Rating All-Time

+3

More Social Data

BIOC in Pulse Portal

Stream of Posts

BIOC Symbol Page

Share BIOC Insights

Express Sentiment

'Buy' or 'Sell' BIOC

BIOC Profile

CEO

Mr. Michael W. Nall

Exchange

Nasdaq

Employees

88.00

About

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell...

BIOC Financials

Annual Financials

Income Statement

Revenue

5.53M

Net Income

(25.14M)

Cash Flow Statement

Change in Cash / Investments

5.88M

Balance Sheet

Cash / Investments

9.3M

Short Term Debt

842,452

Long Term Debt

None

Total Current Assets

13.89M

Total Current Liabilities

5.56M

Total Assets

17.73M

Total Liabilities

6.53M

Stockholder Equity

11.2M

Quarterly Financials

Income Statement

Q Revenue

1.45M

Q Net Income

(8.34M)

Cash Flow Statement

Q Change in Cash / Investments

12.19M

Balance Sheet

Q Cash / Investments

21.49M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

26.26M

Q Total Current Liabilities

6.03M

Q Total Assets

29.81M

Q Total Liabilities

7.08M

Q Stockholder Equity

22.73M

BIOC Charts

10-Year Chart

BIOC 10-Year Chart

5-Year Chart

BIOC 5-Year Chart

1-Year Chart

BIOC 1-Year Chart

6-Month Chart

BIOC 6-Month Chart

3-Month Chart

BIOC 3-Month Chart

1-Month Chart

BIOC 1-Month Chart

1-Day Chart

BIOC 1-Day Chart

ABUS
Data Last Updated: 6 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 159.301M


P/E: N/A

P/S: 26.51

Q P/B: 2.17

Y Rev: 6.01M

Q Rev: 1.49M

Beta: 2.58

ABUS Share Stats

Outstanding Shares

68.96M

Float Shares

49.46M

Percent of Float Short

0.83%

ABUS Insider Stats

Percent Outstanding Insider Ownership

8.45%

Percent Outstanding Institution Ownership

5.5%

ABUS Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ABUS in Pulse Portal

Stream of Posts

ABUS Symbol Page

Share ABUS Insights

Express Sentiment

'Buy' or 'Sell' ABUS

ABUS Profile

CEO

Dr. Frank M. Torti

Exchange

Nasdaq

Employees

80.00

About

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

ABUS Financials

Annual Financials

Income Statement

Revenue

6.01M

Net Income

(153.72M)

Cash Flow Statement

Change in Cash / Investments

(5.14M)

Balance Sheet

Cash / Investments

90.83M

Short Term Debt

340,000

Long Term Debt

18.99M

Total Current Assets

93.83M

Total Current Liabilities

7.83M

Total Assets

105.54M

Total Liabilities

32.79M

Stockholder Equity

72.74M

Quarterly Financials

Income Statement

Q Revenue

1.49M

Q Net Income

(13.86M)

Cash Flow Statement

Q Change in Cash / Investments

(5.38M)

Balance Sheet

Q Cash / Investments

84.89M

Q Short Term Debt

None

Q Long Term Debt

19.38M

Q Total Current Assets

88.33M

Q Total Current Liabilities

4.03M

Q Total Assets

102.61M

Q Total Liabilities

29.36M

Q Stockholder Equity

73.26M

ABUS Charts

10-Year Chart

ABUS 10-Year Chart

5-Year Chart

ABUS 5-Year Chart

1-Year Chart

ABUS 1-Year Chart

6-Month Chart

ABUS 6-Month Chart

3-Month Chart

ABUS 3-Month Chart

1-Month Chart

ABUS 1-Month Chart

1-Day Chart

ABUS 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon